VivaTech 2021

Startup

CURADIGM

Industry
Wed
Thu
D09-003
Deep Tech
Health
Scaling Up

More info

In association  With

Creation

2019

Country

France

Employees

6-15

Development Level

Going to market

Fundraising

Serie A

Fundraising Amount (€)

1000000

Description

Curadigm is an early-stage technology company dedicated to improving outcomes for patients by shifting the therapeutic delivery paradigm. Curadigm's Nanoprimer is designed to increase drug bioavailability while decreasing unintended off-target effects.

Welcome to the online networking tables

Here, you can meet other attendees and network in small groups - through messages, audio calls or video calls.